Effect of SCF in vitro stimulation on hemopoietic progenitor cells (HPC) from patients with myelodysplastic syndromes: Comparison with other growth factors.

被引:0
|
作者
Novelli, EM [1 ]
Ruggieri, L [1 ]
Camba, I [1 ]
机构
[1] IST SCI SAN RAFFAELE,MILAN,ITALY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3560 / 3560
页数:1
相关论文
共 50 条
  • [1] In vitro effects of recombinant hemopoietic growth factors on progenitor cells from patients with myelodysplastic syndromes.
    Carbonell, F
    LopezEspinosa, A
    Sanchez, H
    Blanquer, A
    Miguel, A
    Linares, M
    MiguelGarcia, A
    Sanchez, M
    [J]. BLOOD, 1995, 86 (10) : 3154 - 3154
  • [2] Cycling status of hemopoietic progenitor cells of the marrow from patients with myelodysplastic syndromes (MDS).
    Thanopoulou, E
    Galani, A
    Zoumbos, N
    [J]. BLOOD, 2003, 102 (11) : 326B - 326B
  • [3] INVITRO EFFECTS OF RECOMBINANT HEMATOPOIETIC GROWTH-FACTORS ON PROGENITOR CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    THOMAS, X
    GUYOTAT, D
    CAMPOS, L
    SHI, ZH
    VILA, L
    EHRSAM, A
    FIERE, D
    [J]. LEUKEMIA RESEARCH, 1991, 15 (01) : 29 - 36
  • [4] Hematopoietic progenitor cells from patients with myelodysplastic syndromes:: in vitro colony growth and long-term proliferation
    Flores-Figueroa, E
    Gutiérrez-Espindola, G
    Guerrero-Rivera, S
    Pizzuto-Chavez, J
    Mayani, H
    [J]. LEUKEMIA RESEARCH, 1999, 23 (04) : 385 - 394
  • [5] IN-VITRO GROWTH OF HEMATOPOIETIC PROGENITOR CELLS IN MYELODYSPLASTIC SYNDROMES - EFFECT OF STEM-CELL FACTOR (SCF), IL-6 AND IL-11
    ZWIERZINA, H
    BAMMER, T
    FENAUX, P
    GEISSLER, D
    SCHMALZL, F
    [J]. BLOOD, 1993, 82 (10) : A374 - A374
  • [6] In vitro antithymocyte globulin (ATG) stimulation of hemopoietic stem cells: Correlation with clinical response in patients with aplastic anemia (AA) and myelodysplastic syndromes (MDS).
    Killick, S
    Marsh, JCW
    Gordon-Smith, EC
    Gibson, FM
    [J]. BLOOD, 1998, 92 (10) : 693A - 693A
  • [7] Hypochromic red blood cells in low-risk myelodysplastic syndromes:: effects of treatment with hemopoietic growth factors
    Ljung, T
    Bäck, R
    Hellström-Lindberg, E
    [J]. HAEMATOLOGICA, 2004, 89 (12) : 1446 - 1453
  • [8] Relative participation of progenitor cells in the dysplastic process in patients with myelodysplasia and response to growth factors.
    Thanopoulou, E
    Tselepi, R
    Kouraklis-Symeonidis, A
    Symeonidis, A
    Tsoplou, P
    Zoumbos, N
    [J]. BLOOD, 1998, 92 (10) : 422A - 422A
  • [9] In vitro expansion of repopulating hematopoietic stem cells from patients with Myelodysplastic Syndromes
    Altrock, E.
    Danner, J.
    Jann, J. -C.
    Flach, J.
    Schmitt, N.
    Nowak, V.
    Oblaender, J.
    Pressler, J.
    Palme, I.
    Wuchter, P.
    Drangmeister, L.
    La Meir, F.
    Nolte, F.
    Metzgeroth, G.
    Hofmann, W. -K.
    Nowak, D.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 92 - 92
  • [10] GROWTH ANALYSIS OF MARROW CD34-POSITIVE HEMATOPOIETIC PROGENITOR CELLS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    ASANO, H
    HOTTA, T
    ICHIHARA, M
    MURATE, T
    KOBAYASHI, M
    SAITO, H
    [J]. LEUKEMIA, 1994, 8 (05) : 833 - 838